Donate Now. Secure Donations through Network for Good.

Visit BCA on YouTube

 

Calendar

December 9-13, 2009

Henry B. Gonzalez Convention Center,

San Antonio, Texas, USA


More events

BCA News

USPSTF Releases New Screening Guidelines

Mammography screening is in the news again. The US Prevention Services Task Force has announced new guidelines for breast cancer screening that would mean women get fewer mammograms. This is good news.

Read BCA’s analysis of the new recommendations here. On the issue of prevention, click here for information on why words matter.


The Fall Issue of The Source Is Now Available Online

Sign up here to receive The Source direct to your inbox four times a year.

In this issue:

A Whole New Level of Pinkwashing: Eli Lilly is Milking Cancer

Breast Cancer Awareness Month: The Present Looks Like the Past

Making Changes That Matter

GoodGuide: A Tool to Make Companies Do the Right Thing


Think Before You Pink wins 2009 BENNY Award

BCA's victorious 2008 Think Before You Pink campaign, "Yoplait: Put a Lid on it" won the first place 2009 BENNY Award from the Business Ethics Network. The annual BENNY Awards recognize outstanding corporate campaign victories.

Learn about the campaign here.


Think Before You Pink Is In The News!

This month, our Think Before You Pink campaign has been covered in major news outlets like Newsweek, the Boston Globe and the Huffington Post!  Visit the "In The News" page to read the latest articles about Think Before You Pink.

Eli Lilly is Milking Cancer

BCA is targeting Eli Lilly with this year's Think Before You Pink campaign.

Eli Lilly is now the sole manufacturer of rBGH — the artificial growth hormone given to dairy cows that increases people’s risk of cancer. Eli Lilly also manufactures breast cancer treatment medications and a pill that “reduces the risk” of breast cancer. It's a perfect profit circle. Eli Lilly is milking cancer. Tell them to stop making rBGH.


BCA Victory at the FDA

BCA's testimony at the FDA helped to secure a victory for patients.

The Oncologic Drug Advisory Committee opposed Ortho Biotech’s request to approve Doxil for metastatic breast cancer.    We will make sure the FDA Commissioner follows the committee’s recommendation. Read BCA's statement here.


Support BCA Through Facebook's Birthday Wish

Facebook Birthday WishRather than get a bunch of gifts you don't really need, why not ask your friends to make a gift that will help those affected by breast cancer? It's easy to do when you set up your Facebook Birthday Wish Page!

 


Breast Cancer Action Sues to End Gene Patenting


BCA is a plaintiff in a lawsuit filed on May 12, challenging Myriad Genetics' patents on BRCA1 and BRCA2, the “breast cancer genes.”

Read our press release to learn more about the case and why BCA joined it.

BCA is the only breast cancer organization involved in the suit because we are the watchdogs of the breast cancer movement and we don't take money from companies that profit from or contribute to cancer.

Your support makes this important work possible!


CA Safe Cosmetics Program Implemented

The California Safe Cosmetics Act, which BCA cosponsored and helped to pass in 2005, has finally begun implementation!  Cosmetics manufacturers are now required to report any ingredients in their products known or suspected to cause cancer, birth defects, or other reproductive harm.  Learn more about the California Safe Cosmetics Program.

Overexposed and Underinformed

Breast Cancer Action is proud to be a contributing member to the California Healthy Nail Salon's recently released Report and Policy Agenda,

Overexposed and Underinformed: Dismantling Barriers to Health and Safety in California Nail Salons

Download the report here.

Learn more about the California Healthy Nail Salon Collaborative.